Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Assets Average (2021 - 2026)

RxSight filings provide 5 years of Assets Average readings, the most recent being $310.2 million for Q4 2025.

  • On a quarterly basis, Assets Average fell 1.38% to $310.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $310.2 million, a 1.38% decrease, with the full-year FY2025 number at $315.2 million, up 25.8% from a year prior.
  • Assets Average hit $310.2 million in Q4 2025 for RxSight, roughly flat from $308.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $315.8 million in Q1 2025 to a low of $149.3 million in Q3 2021.
  • Median Assets Average over the past 5 years was $193.4 million (2021), compared with a mean of $225.6 million.
  • Biggest five-year swings in Assets Average: fell 22.85% in 2022 and later skyrocketed 72.7% in 2025.
  • RxSight's Assets Average stood at $198.2 million in 2021, then decreased by 22.85% to $152.9 million in 2022, then grew by 19.14% to $182.2 million in 2023, then soared by 72.62% to $314.5 million in 2024, then dropped by 1.38% to $310.2 million in 2025.
  • The last three reported values for Assets Average were $310.2 million (Q4 2025), $308.8 million (Q3 2025), and $311.0 million (Q2 2025) per Business Quant data.